newsfilter
← Latest News
GlobeNewswire·

Eliem Therapeutics to Participate at Two Upcoming Investor Conferences

SEATTLE and CAMBRIDGE, United Kingdom, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to